Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Completed 1Active not recruiting 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2Other solid neoplasm 2

Conditions

Glioblastoma 8Breast Neoplasms 7Prostatic Neoplasms 6Lung Neoplasms 6Carcinoma, Non-Small-Cell Lung 6Urinary Bladder Neoplasms 5Glioma 5Astrocytoma 5Oropharyngeal Neoplasms 4Esophageal Neoplasms 4Carcinoma 4Burkitt Lymphoma 4Squamous Cell Carcinoma of Head and Neck 3Sarcoma 3Rectal Neoplasms 3Neoplasm Metastasis 3Adenocarcinoma of Lung 3Uterine Cervical Neoplasms 2Triple Negative Breast Neoplasms 2Sarcoma, Ewing 2Pancreatic Neoplasms 2Neoplasms 2Mouth Neoplasms 2Mesothelioma, Malignant 2Melanoma 2Liposarcoma 2Laryngeal Neoplasms 2Hodgkin Disease 2Gliosarcoma 2Ganglioneuroblastoma 2

Interventions

Platinum 3Pemetrexed 3Cisplatin 31,2-diaminocyclohexaneplatinum II citrate 3pembrolizumab 2Radiotherapy 2Radiation 2cediranib 1atezolizumab 1Radiotherapy, Intensity-Modulated 1Pharmacogenomic Testing 1Combined Modality Therapy 1Cerebral Decortication 1Carboplatin 1Brentuximab Vedotin 1Blood Component Removal 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Mesothelioma, Malignant × Radiation × 30 days × Clear all
NCT03228537 2026-05-29

Atezolizumab, Pemetrexed Disodium, Cisplatin, and Surgery With or Without Radiation Therapy in Treating Patients With Stage I-III Pleural Malignant Mesothelioma

National Cancer Institute (NCI)

Phase 1 Active not recruiting
28 enrolled 17 charts
Other solid neoplasmThoracic

Mesothelioma, Malignant

NCT02959463 2026-05-27

Pembrolizumab After Radiation Therapy in Treating Patients With Pleural Malignant Mesothelioma

M.D. Anderson Cancer Center

Phase 1 Completed
25 enrolled 11 charts
Other solid neoplasmThoracic

Mesothelioma, Malignant

Data powered by HemOnc (CC BY 4.0) Colophon âš¡